Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes

Journal of Virology

Volumn 71, Issue 6, 1997, Pages 4589-4598

  Mayer, Anna ^a   Podlech, Jürgen ^a   Kurz, Sabine ^a   Steffens, Hans Peter ^a   Maiberger, Sabine ^a   Thalmeier, Karin ^b   Angele, Peter ^c   Dreher, Liane ^c   Reddehase, Matthias J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; STEM CELL FACTOR;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APLASTIC ANEMIA; ARTICLE; BONE MARROW APLASIA; CYTOMEGALOVIRUS INFECTION; FEMALE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN CYTOMEGALOVIRUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA; VIRUS PATHOGENESIS;

EID: 0030925027     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.6.4589-4598.1997     Document Type: Article

References (52)

1. Alonso, S., A. Minty, Y. Bourlet, and M. Buckingham. 1986. Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J. Mol. Evol. 23:11-22.
2. Anderson, D. M., S. D. Lyman, A. Baird, J. M. Wignall, J. Eisenman, C. Rauch, C. J. March, H. S. Boswell, S. D. Gimpel, D. Cosman, and D. E. Williams. 1990. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63:235-243.
3. Apperley, J. F., C. Dowding, J. Hibbin, J. Buiter, E. Matutes, P. J. Sissons, M. Gordon, and J. M. Goldman. 1989. The effect of cytomegalovirus on hematopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp. Hematol. 17:38-45.
4. Badley, J. E., G. A. Bishop, T. St. John, and J. A. Frelinger. 1988. A simple, rapid method for the purification of poly A+ RNA. BioTechniques 6:114-116.
5. Baumhueter, S., N. Dybdal, and L. A. Lasky. 1994. Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood 84:2554-2565.
6. Bühler, B., G. M. Keil, F. Weiland, and U. H. Koszinowski. 1990. Characterization of the murine cytomegalovirus early transcription unit el that is induced by immediate-early proteins. J. Virol. 64:1907-1919.
7. Busch, F. W., W. Mutter, U. H. Koszinowski, and M. J. Reddehase. 1991. Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma. J. Virol. 65:981-984.
8. Chabannon, C., and B. Torok-Storb. 1992. Stem cell-stromal cell interactions. Curr. Top. Microbiol. Immunol. 177:123-136.
9. Childs, B., and D. Emanuel. 1993. Cytomegalovirus infection and compromise. Exp. Hematol. 21:198-200. (Editorial.)
10. Chiu, C. P., C. Moulds, R. L. Coffman, D. Rennick, and F. Lee. 1988. Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells. Proc. Natl. Acad. Sci. USA 85:7099-7103.
11. Einsele, H., G. Ehninger, M. Steidle, I. Fischer, S. Bihler, F. Gerneth, A. Vallbracht, H. Schmidt, H. D. Waller, and C. A. Müller. 1993. Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood 82:1672-1678.
12. Flanagan, J. G., D. C. Chan, and P. Leder. 1991. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 64:1025-1035.
13. Forman, S. J., and J. A. Zaia. 1994. Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? Blood 83:2392-2398.
14. Fries, B. C., D. Khaira, M. S. Pepe, and B. Torok-Storb. 1993. Declining lymphocyte counts following cytomegalovirus (CMV) infection are associated with fatal CMV disease in bone marrow transplant patients. Exp. Hematol. 21:1387-1392.
15. Gibbons, A. E., P. Price, and G. R. Shellam. 1995. Analysis of hematopoietic stem and progenitor cell populations in cytomegalovirus-infected mice. Blood 86:473-481.
16. Gubbay, J., J. Collignon, P. Koopman, B. Capel, A. Economou, A. Münsterberg, N. Vivian, P. Goodfellow, and R. Lovell Badge. 1990. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature 346:245-250.
17. Hudson, J. B., V. Misra, and T. R. Mosmann. 1976. Cytomegalovirus infectivity: analysis of the phenomenon of centrifugal enhancement of infectivity. Virology 72:235-243.
18. Ikebuchi, K., G. G. Wong, C. G. Clark, J. N. Ihle, Y. Hirai, and M. Ogawa. 1987. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc. Natl. Acad. Sci. USA 84:9035-9039.
19. Ikuta, K., and I. L. Weissman. 1992. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc. Natl. Acad. Sci. USA 89:1502-1506.
20. + T lymphocytes. J. Exp. Med. 169:1199-1212.
21. Keil, G. M., A. Ebeling-Keif, and U. H. Koszinowski. 1987. Sequence and structural organization of murine cytomegalovirus immediate-early gene 1. J. Virol. 61:1901-1908.
22. Keil, G. M., M. R. Fibi, and U. H. Koszinowski. 1985. Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus. J. Virol. 54:422-428.
23. Kondo, K., H. Kaneshima, and E. S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91:11879-11883.
24. Konecki, D. S., J. Brennand, J. C. Fuscoe, C. T. Caskey, and A. C. Chinault. 1982. Hypoxanthine-guanine phosphoribosyltransferase genes of mouse and Chinese hamster: construction and sequence analysis of cDNA recombinants. Nucleic Acids Res. 10:6763-6775.
25. Koszinowski, U. H., M. Del Val, and M. J. Reddehase. 1990. Cellular and molecular basis of the protective immune response to cytomegalovirus infection. Curr. Top. Microbiol. Immunol. 154:189-220.
26. Kurz, S., H.-P. Steffens, A. Mayer, J. R. Harris, and M. J. Reddehase. 1997. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol. 71:2980-2987.
27. Lagneaux, L., A. Delforge, R. Snoeck, E. Bosmans, D. Schols, E. DeClercq, P. Stryckmans, and D. Bron. 1996. Imbalance in production of cytokines by bone marrow stromal cells following cytomegalovirus infection. J. Infect. Dis. 174:913-919.
28. Lagneaux, L., A. Delforge, R. Snoeck, P. Stryckmans, and D. Bron. 1994. Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells Exp. Hematol. 22:26-30.
29. Maciejewski, J. P., E. E. Bruening, R. E. Donahue, E. S. Mocarski, N. S. Young, and S. C. St. Jeor. 1992. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170-178.
30. Meyers, J. D., N. Flournoy, and E. D. Thomas. 1986. Risk factors for cytomegalovirus infection after human marrow transplantation. J. Infect. Dis. 153:478-488.
31. Minton, E. J., C. Tysoe, J. H. Sinclair, and J. G. Sissons. 1994. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68:4017-4021.
32. Mutter, W., M. J. Reddehase, F. W. Busch, H. J. Bühring, and U. H. Koszinowski. 1988. Failure in generating hematopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J. Exp. Med. 167:1645-1658.
33. Plachter, P., C. Sinzger, and G. Jahn. 1996. Cell types involved in replication and distribution of human cytomegalovirus. Adv. Virus Res. 46:195-261.
34. Qiu, F., P. Ray, K. Brown, P. E. Barker, S. Jhanwar, F. H. Ruddle, and P. Besmer. 1988. Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family. EMBO J. 7:1003-1011.
35. Rapp, M., M. Messerle, B. Bühler, M. Tannheimer, G. M. Keil, and U. H. Koszinowski. 1992. Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus. J. Virol. 66: 4399-4406.
36. Reddehase, M. J., L. Dreher-Stumpp, P. Angele, M. Balthesen, and M. Susa. 1992. Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma. Ann. Hematol. 64(Suppl. A):A125-A127.
37. Reddehase, M. J., S. Jonjic, F. Weiland, W. Mutter, and U. H. Koszinowski. 1988. Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. J. Virol. 62:1061-1065.
38. Reddehase, M. J., W. Mutter, and V. H. Koszinowski. 1987. In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection. J. Exp. Med. 165:650-656.
39. Reddehase, M. J., F. Weiland, K. Münch, S. Jonjic, A. Lüske, and U. H. Koszinowski. 1985. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55:264-273.
40. Riddell, S. R., K. S. Watanabe, J. M. Goodrich, C. R. Li, M. E. Agha, and P. D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238-241.
41. Rubocki, R. J., T. H. Hansen, and D. R. Lee. 1986. Molecular studies of murine mutant BALB/c-H-2-dm2 define a deletion of several class I genes including the entire H-2Ld gene. Proc. Natl. Acad. Sci. USA 83:9606-9610.
42. Russell, E. S. 1979. Hereditary anemias of the mouse: a review for geneticists. Adv. Genet. 20:357-459.
43. Scalzo, A. A., N. A. Fitzgerald, A. Simmons, A. B. La Vista, and G. A. Shellam. 1990. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171:1469-1483.
44. Shaklai, M. 1989. Cellular components of stroma in vivo in comparison with in vitro systems, p. 219-251. In M. Tavassoli (ed.), Handbook of the hematopoietic microenvironment. Humana Press, Clifton, N.J.
45. Shirai, A., K. Holmes, and D. Klinman. 1993. Detection and quantitation of cells secreting IL-6 under physiologic conditions in BALB/c mice. J. Immunol. 150:793-799.
46. Simmons, P., K. Kaushansky, and B. Torok-Storb. 1990. Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc. Natl. Acad. Sci. USA 87:1386-1390.
47. Sredni, B., Z. Rosenthal-Galili, H. Michlin, D. Sobelman, Y. Seger, S. Blagerman, Y. Kalechman, and B. Rager-Zisman. 1994. Restoration of murine cytomegalovirus (MCMV) induced myelosuppression by AS101. Immunol. Lett. 43:159-165.
48. Tsuchiya, M., S. Asano, Y. Kaziro, and S. Nagata. 1986. Isolation and characterization of the cDNA for murine granulocyte colony-stimulating factor. Proc. Natl. Acad. Sci. USA 83:7633-7637.
49. Weiland, F., G. M. Keil, M. J. Reddehase, and U. H. Koszinowski. 1986. Studies on the morphogenesis of murine cytomegalovirus. Intervirology 26: 192-201.
50. Williams, D. E., P. de Vries, A. E. Namen, M. B. Widmer, and S. D. Lyman. 1992. The Steel factor. Dev. Biol. 151:368-376.
51. Yuhasz, S. A., V. B. Dissette, M. L. Cook, and J. G. Stevens. 1994. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. Virology 202:272-280.
52. Zsebo, K. M., D. A. Williams, E. N. Geissler, V. C. Broudy, F. H. Martin, H. L. Atkins, R. Y. Hsu, N. C. Birkett, K. H. Okino, D. C. Murdock, F. W. Jacobsen, K. E. Langley, K. A. Smith, T. Takeishi, B. M. Cattanach, S. J. Galli, and S. V. Suggs. 1990. Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213-224.